Quote & Headlines
StockTalk
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
VC Financings Boost Interest in BiotechThe Burrill Report • Fri, Jul 24, 2009
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008Market Folly • Thu, Jan 15, 2009
-
Biotech ETFs a Rare Safe HavenTom Lydon • Fri, Nov 14, 2008
-
Four Thoughts on the Imclone/Lilly DealDerek Lowe • Tue, Oct 7, 2008
-
Discovery Labs: The Next Biotech Buy?Mike Havrilla • Mon, Oct 6, 2008
To learn more about Seeking Alpha Pro, click here.
-
ImClone Jumps on Lung Cancer ResultsRoy Mehta • Tue, Sep 11, 2007
-
ImClone Shares Tumble on Rumors of Cancer Drug ShortfallSA Editor Eli Hoffmann • Wed, May 16, 2007
-
Icahn Hopes to 'Get Lucky Again' with ImCloneSteven Towns • Thu, Oct 26, 2006
-
ImClone Systems: Will It Benefit From a Dose of Carl Icahn?10Q Detective • Mon, Sep 25, 2006
-
Carl Icahn Asks Imclone Chairman To Step DownLon Juricic • Thu, Sep 21, 2006
-
VC Financings Boost Interest in BiotechThe Burrill Report • Fri, Jul 24, 2009
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008Market Folly • Thu, Jan 15, 2009
-
Biotech ETFs a Rare Safe HavenTom Lydon • Fri, Nov 14, 2008
-
Four Thoughts on the Imclone/Lilly DealDerek Lowe • Tue, Oct 7, 2008
-
Discovery Labs: The Next Biotech Buy?Mike Havrilla • Mon, Oct 6, 2008
-
ImClone Systems, Inc. Q1 2008 Earnings Call TranscriptTue, Apr 29, 2008
-
ImClone Systems, Inc. Q1 2008 Earnings Call TranscriptFri, Apr 25, 2008 • 3 Comments
-
ImClone Systems Inc. Q4 2007 Earnings Call TranscriptMon, Feb 4, 2008
-
ImClone Systems Inc. Q3 2007 Earnings Call TranscriptFri, Oct 26, 2007
-
at CNBC.com (Nov 23, 2010)
Company Description
We are a biopharmaceutical company whose mission is to advance oncology care by developing and commercializing a portfolio of targeted treatments designed to address the medical needs of patients with cancer. We focus on what we believe are two promising strategies for treating cancer: growth... More
Country: United States